Clinical characteristics | Patient groups | In total | t or χ2value | Pvalue | Patent grafts (n=231) | Poor patent grafts (n=110) | Sex | | | | | | Male, n (%) | 188(81.4) | 85(77.3) | 273 | 0.79 | 0.37 | Female, n (%) | 43(18.6) | 25(22.7) | 68 | Age, years | 62.7±10.3 | 62.5±10.0 | 62.6±10.2 | 0.42 | 0.87 | Bypass grafts, n (%) | 574 | 320 | 894 | | | Body Mass Index | 30.1±5.8 | 30.5±6.1 | 30.2±5.9 | 0.55 | 0.45 | History of | | | | | | Diabetes, n (%) | 72(31.2) | 41(37.3) | 113 | 1.25 | 0.26 | Hypertension, n (%) | 157(68.0) | 61(55.5) | 218 | 5.06 | 0.025 | Dyslipidemia, n (%) | 58(25.1) | 38(34.5) | 96 | 3.28 | 0.07 | Smoking, n (%) | 118(51.1) | 48(43.6) | 166 | 1.65 | 0.20 | Cerebrovascular disease, n (%) | 28 (12.1) | 26 (23.6) | 54 | 7.41 | 0.006 | Post-operative adjuvant medication | | | | | | Beta blocker, n (%) | 101(43.7) | 48(43.6) | 149 | 0.00 | 0.98 | ACE inhibitor, n (%) | 58(25.1) | 27(24.5) | 85 | 0.01 | 0.9 | Statin, n (%) | 107(46.3) | 49(44.5) | 156 | 0.10 | 0.76 | Calcium channel blocker, n (%) | 21(9.1) | 9(8.2) | 30 | 0.08 | 0.78 | Symptomatic, n (%) | 39(16.9) | 15(13.6) | 54 | 0.59 | 0.44 |
|